Roivant Sciences Earnings
NASDAQ: ROIVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
35.44+1.23 (+3.60%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Roivant Sciences earnings summary
In its most recent report on Aug 6, 2026 (Q1 2026), ROIV posted EPS of $-0.26. Revenue for the quarter was $1.4 million. Across the last 16 reports, ROIV shares moved an average of 2.9% (in either direction) in the first trading session after results, rising 13 times and falling 3 times.
Summary generated from market data by MetaCap's automated system. Methodology
ROIV earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.26 | — | -0.4% |
| May 20, 2026 | — | $0.34 | — | +0.1% |
| Feb 6, 2026 | — | $-0.38 | — | +2.4% |
| Nov 10, 2025 | — | $-0.17 | — | -0.3% |
| Aug 11, 2025 | — | $-0.33 | — | +0.6% |
| May 29, 2025 | — | $-0.28 | — | +2.2% |
| Feb 10, 2025 | — | $0.23 | — | +1.1% |
| Nov 12, 2024 | — | $-0.31 | — | +11.9% |
| Aug 9, 2024 | — | $0.12 | — | +0.6% |
| May 30, 2024 | — | $-0.02 | — | +1.1% |
| Feb 13, 2024 | — | $6.03 | — | +0.1% |
| Nov 13, 2023 | — | $-0.40 | — | +1.8% |
| Aug 14, 2023 | — | $-0.38 | — | +2.5% |
| Jun 28, 2023 | — | $-0.03 | — | +7.1% |
| Feb 13, 2023 | — | $-0.49 | — | -10.3% |
| Nov 14, 2022 | — | $-0.42 | — | +3.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.